Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients Aged 80 Years or Older: A Retrospective Analysis

Molecular and Clinical Oncology - United Kingdom
doi 10.3892/mco.2014.453
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Elderly Patients With Advanced Non-Small Cell Lung Cancer

Current Gerontology and Geriatrics Research
GerontologyGeriatrics
2010English

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors vs Conventional Chemotherapy in Non–Small Cell Lung Cancer Harboring Wild-Type Epidermal Growth Factor Receptor

JAMA - Journal of the American Medical Association
Medicine
2014English

The Treatment of Metastatic Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors

2013English

Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2008English

Estrogen Receptor Β1 Activation Accelerates Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer

Oncology Reports
MedicineCancer ResearchOncology
2018English

Early Radiographic Response to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor in Non-Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor Mutations: A Prospective Study

Biomedical Journal
Medicine
2015English

Clinical Characteristics and Response to Tyrosine Kinase Inhibitors of Patients With Non-Small Cell Lung Cancer Harboring Uncommon Epidermal Growth Factor Receptor Mutations

Chinese Journal of Cancer Research
Cancer ResearchOncology
2017English

Identification of Epidermal Growth Factor Receptor Tyrosine-Kinase Mutations in Non-Small Cell Lung Cancer: Testing Platform Matters

Cureus
2020English

Association of Initial Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Treatment and EGFR Exon 19 Deletion With Frequency of the T790M Mutation in Non-Small Cell Lung Cancer Patients After Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

OncoTargets and Therapy
OncologyPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy